Two Different Regimens of Misoprostol in Retained Placenta

Status Completed

Clinical Trial Summary

This study evaluates intra umbilical vein injection of 800 µg versus 400 µg misoprostol for the treatment of retained placenta to reduce the need of manual removal of placenta under general anaesthesia

Clinical Trial Description

The third stage of labor may be complicated by retained placenta, which may cause severe bleeding and infection, with a potentially fatal outcome. Manual removal of placenta is the current standard of management of retained placenta which usually requires general or regional anaesthesia at a hospital and it is an invasive procedure that may lead to bleeding, trauma and infection. Intraumbilical injection of uterotonic agent( misoprostol) is an easy, non invasive procedure. A randomized clinical trial are required to determine the difference between two doses of misoprostol 400 versus 800 micro gram for management of retained placenta ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02704780
Study type	Interventional
Source	Hawler Medical University
Contact
Status	Completed
Phase	Phase 2
Start date	March 2016
Completion date	February 14, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02509351` - Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?	Phase 2/Phase 3
Completed	`NCT01931423` - The Influence of Placental Drainage of Management of the Third Stage of Labor:a Randomized Controlled Study	N/A
Completed	`NCT00499005` - Carbetocin Versus Syntometrine for the Third Stage of Labour	Phase 4
Completed	`NCT01485562` - Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home Births	N/A
Completed	`NCT01359878` - Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial	Phase 2/Phase 3
Completed	`NCT00872469` - World Maternal Antifibrinolytic Trial	Phase 3
Not yet recruiting	`NCT02396303` - Carbetocin Versus Oxytocin in Caesarean Section for the Control of Postpartum Haemorrhage	Phase 0
Completed	`NCT01931410` - The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a Randomized Controlled Trial	Phase 4
Completed	`NCT01895218` - Treatment of Women After Postpartum Haemorrhage	Phase 3
Recruiting	`NCT02187874` - Timing of Umbilical Cord Occlusion in Premature Babies( <33 w). Delayed vs Early.	N/A
Withdrawn	`NCT01910675` - PCC and Fibrinogen Compared With FFP in PPH	Phase 4
Completed	`NCT02562300` - Uterotonics Using to Reduce Bleeding at Cesarean Section	Phase 2
Completed	`NCT01044082` - Prevention of Post-partum Haemorrhage	N/A
Completed	`NCT01116050` - Intrarectal Misoprostol in Postpartum Haemorrhage	Phase 3
Completed	`NCT02149472` - Towards Better Prognostic and Diagnostic Strategies for Haemostatic Changes During Major Obstetric Haemorrhage
Recruiting	`NCT02492087` - Topical Tranexamic Acid in Caesarean Section	Phase 3
Completed	`NCT02468310` - Evaluating the Effects of SMS Text Messaging Support System Among Frontline Health Workers in Ghana	N/A
Recruiting	`NCT02136719` - Bimanual Uterine Compression to Reduce Blood Loss and Prevent Postpartum Haemorrhage After Vaginal Delivery	N/A